Blueprint Medicines [BPMC] vs S&P 500 [^GSPC] Detailed Stock Comparison
Blueprint Medicines
NASDAQ
Loading...
S&P 500
index
Loading...
Index Comparison
You are comparing market indices. Financial metrics such as P/E ratios, dividend yields, and financial statements are not available for indices as they represent market benchmarks rather than individual companies.
Available data includes: price performance, historical charts, and basic market statistics.
Performance
Key Stats
Blueprint Medicines vs S&P 500 Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Blueprint Medicines | 0.00% | 0.12% | 1.05% | 53.79% | 15.63% | 48.46% |
| S&P 500 | -0.29% | 0.94% | 3.30% | 9.01% | 5.22% | 9.90% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Blueprint Medicines | 12.60% | 149.54% | 73.38% | 370.76% | 598.65% | 598.65% |
| S&P 500 | 16.12% | 52.53% | 89.86% | 227.25% | 501.83% | 428.80% |